188
L. Fan et al. / Phytochemistry Letters 14 (2015) 185–189
Table 3
20:80; 25:75; 30:70, each 4.5 L) as the eluent to give six
In vitro anti-RSV activity of compounds 1–7.
subfractions (Fr. 2–1-Fr. 2–6). Fr. 2–3 (230 mg) was subsequently
purified by preparative HPLC [CH3CN–H2O (0.1% TFA), 25:75, 6 mL/
min] to yield compounds 1 (7 mg), 2 (17 mg), and 3 (11 mg). Fr. 2–2
(325 mg) was purified by preparative HPLC [CH3CN–H2O (0.1%
TFA), 20:80, 6 mL/min] to obtain compounds 4 (15 mg) and 5
(12 mg). Fr. 1 (6 g) was then subjected to an ODS column
(4 ꢁ 30 cm) eluted with gradient mixtures of MeOH–H2O (5:95;
10:90; 15:85; 20:80; 25:75; 30:70, each 4.5 L) to afford six
subfractions (Fr. 1–1-Fr. 1–6). Fr. 1–4 (563 mg) was purified by
preparative HPLC [MeOH–H2O (0.1% TFA), 45:55, 6 mL/min] to give
compounds 6 (21 mg), 7 (30 mg), and 8 (7 mg).
Compoundsa RSV long strain
RSV A2 strain
CC50 (m
g/mL)c
IC50
(
m
g/mL)b SId
IC50
(m
g/mL) SI
1
2
3
4
5
6
7
NAf
NA
NA
32.0
NA
2.5
2.5
2.5
–
–
–
NA
NA
NA
32.0
NA
–
–
–
>200.0
>200.0
>200.0
>200.0
>200.0
>6.3
–
>6.3
–
>80.0 3.0
>80.0 2.2
>66.7 >200.0
>90.9 >200.0
Ribavirine
20.0
2.5
20.0
50.0 ꢄ 2.3
“-” means no detection.
a
The purity of all tested compounds is greater than 98%.
IC50 is the concentration that reduced 50% of CPE in respect to virus control.
CC50 is the concentration of sample with half maximal inhibition on the growth
b
c
3.1.3. 4-O-feruloyl-3-O-syringoyl quinic acid methyl ester (1)
Yellow oil; ½a D
ꢂ
25: - 68.3 (c 0.13, MeOH); UV (MeOH) lmax (log
e):
and survival of HEp-2 cells.
216 (4.45), 288 (4.15), 327 (4.10) nm; IR (KBr): nmax 3414, 1716,
1603, 1517, 1458, 1424, 1334, 1274, 1210, 1119 cmꢀ1; HR–ESI–MS m/
z: 563.1759 [M + H]+ (calcd for C27H31O13, 563.1759); 1H NMR
(DMSO-d6, 400 MHz) and 13C NMR (DMSO-d6, 100 MHz) data, see
Table 1.
d
SI is selective value = CC50/IC50.
e
Ribavirin (purity ꢅ98%) is the positive control in the test.
f
NA means no active.
3. Materials and methods
3.1. General experimental procedures
3.1.4. 7-O-[6-O-(1-O-vanillic acid 4-O-
glucopyranosyl]-6-methoxy coumarin (2)
25: - 51.0 (c 0.23, MeOH); UV (MeOH) lmax (log
e):
b-D-glucopyranosyl)-b-D-
Optical rotations were recorded by using a JASCO P-1020
polarimeter. UV spectra were measured on a JASCO V-550 UV/vis
spectrophotometer with a 1 cm length cell. IR spectra were
recorded on a JASCO FT/IR-480 plus FT-IR spectrometer. NMR
spectra were recorded on Bruker AV-400 and AV-300 spectrom-
eters. HR–ESI–MS data were obtained on an Agilent 6210 ESI/TOF
mass spectrometer. Macroporous resin Diaion HP-20 (Mitsubishi
Yellow oil; ½a D
ꢂ
204 (4.26), 218 (4.11), 255 (3.81), 291 (3.64), 342 (3.55) nm; IR
(KBr): nmax 3395, 1715, 1614, 1571, 1509, 1456, 1420, 1279, 1086,
1035 cmꢀ1
C
;
HR-ESI–MS m/z: 689.1687 [M + Na]+ (calcd for
30H34NaO17, 689.1688); 1H NMR (DMSO-d6, 400 MHz) and 13C
NMR (DMSO-d6, 100 MHz) data, see Table 2.
Chemical Corporation), MCI gel (75–150
mm; Mitsubishi), ODS
3.2. Acid hydrolysis and HPLC analysis of compound 8
(50 m; YMC) and Sephadex LH-20 (Pharmacia) were used for
m
column chromatography. TLC analyses were carried out using
precoated silica gel GF254 plates (Yantai Chemical Industry
Research Institute). Analytic high-performance liquid chromatog-
raphy (HPLC) was performed on an Agilent chromatography
equipped with a G1311C pump and a G1315D diode-array detector
Compound 8 (2 mg) was hydrolyzed with 2 mol/L HCl (5 mL) at
80 ꢃC for 2 h. The solution was then evaporated under reduced
pressure, after which 1 mL of pyridine and 2 mg of L-cysteine
methyl ester hydrochloride were added to the residue, and the
reaction mixture was heated at 60 ꢃC for 1 h. O-tolyl isothiocyanate
(5 m
L) was added to the mixture and heated at 60 ꢃC for an
(DAD) with a Cosmosil 5C18-MS-II column (4.6 ꢁ 250 mm, 5
mm).
Preparative HPLC was carried out on an Agilent instrument
equipped with a G1310B pump and a G1365D detector with a
additional 1 h. The reaction mixture was then analyzed by HPLC
and detected at 250 nm. Analytical HPLC was performed on a
Cosmosil 5C18-MS-II column (4.6 ꢁ 250 mm, 5
CH3CN-0.05% CH3COOH in H2O (25:75, 1.0 mL/min) as the mobile
phase. -Glucose (tR 16.36 min) was identified as the sugar moiety
of compound 8 based on comparison with authentic samples of
m
m) at 20 ꢃC using
Cosmosil 5C18-MS-II Waters column (20 ꢁ 250 mm, 5
mm).
3.1.1. Plant material
D
The roots and stems of E. obtusifolia were collected in Haikou
city, Hainan province of PR China, in June of 2010 and authenticated
by Prof. Guang-Xiong Zhou (Institute of Traditional Chinese
D
-
glucose (tR 16.36 min) and L-glucose (tR 14.99 min) (Tanaka et al.,
2007).
Medicine
& Natural Products, Jinan University). A voucher
specimen (No.100605) was deposited at the Institute of Traditional
Chinese Medicine & Natural Products, Jinan University, Guangzhou,
PR China.
3.3. Antiviral assay
3.3.1. Cells and viruses
Human larynx epidermoid carcinoma (HEp-2, ATCC CCL-23)
cells, as well as RSV A2 (ATCC-VR-1540) and Long (ATCC-VR-26)
strains were purchased from the Medicinal Virology Institute,
Wuhan University. HEp-2 cells were grown in Dulbecco Modified
Eagle Medium (DMEM, Gibco) supplemented with 10% fetal bovine
serum (FBS, Gibco) and antimicrobials (growth medium, GM), then
cultured at 37 ꢃC in a humidified atmosphere supplied with 5% CO2.
For RSV propagation, RSV stock diluted using DMEM with 2% FBS
and antimicrobials (maintenance medium, MM) was added to the
confluent HEp-2 cells and continually cultured in the incubator
until the maximal RSV syncytia formation. Virus titers were
3.1.2. Extraction and isolation
The air-dried roots and stems of E. obtusifolia (20.0 kg) were
powdered and extracted with 95% (V/V) EtOH under reflux twice
(2 ꢁ 200 L, 2 h each). The EtOH extract was concentrated under
vacuum to afford a residue (963 g), which was suspended in H2O
and then partitioned successively with EtOAc and n-BuOH. After
removing the solvent, the n-BuOH soluble fraction (273 g) was
subjected to macroporous resin HP-20 column (15 ꢁ 60 cm) eluted
with EtOH–H2O mixtures (10:90; 30:70; 50:50; 70:30; 95:5, V/V,
each 30 L). The 30% EtOH eluate (77 g) was subjected to an MCI gel
column (7 ꢁ60 cm) using gradient mixtures of MeOH–H2O (0:100;
10:90; 15:85; 20:80; 25:75; 30:70; 40:60; 50:50; 100:0, each 15 L)
as the eluent to afford twelve fractions (Fr. 1-Fr. 12). Fr. 2 (7 g) was
separated by an ODS column (4 ꢁ 30 cm) with MeOH–H2O (15:85;
determined by the 50% tissue culture-infective dose (TCID50
)
method. The virus stock was stored at ꢀ80 ꢃC until use.